Categories
2020 Election Coronavirus vaccine Covid vaccine Intelwars Life liberty & levin Mark Levin President Trump President trump interview

Trump warns US could become Venezuela on steroids, tells Mark Levin: Biden ‘doesn’t know he’s alive’

With only a month and a half until the 2020 election, President Donald Trump gave an in-depth interview on Fox News’ “Life, Liberty, & Levin,” where he discussed the potential coronavirus vaccine, Joe Biden, mail-in voting, and the mainstream media.

“You know it and I know it, Joe doesn’t know he’s alive,” Trump said of the former vice president. “It’s a sad thing that’s going on. The whole thing is a sad thing.”

Trump called Biden’s running mate Kamala Harris the “most liberal person in the Senate.”

The president warned that if policies from far-left Democrats are instituted, the U.S. could become the next Venezuela.

“And I used to say we’ll be another Venezuela, but I never really…I don’t know that I believed it fully,” he revealed. “That wasn’t too long ago. But I do. If that kind of stuff gets put in, we will be another Venezuela, except on major steroids.”

Trump called former White House national security adviser John Bolton a “stupid person.” He added, “What he did, I think was highly illegal, I mean his book is loaded up with confidential and classified information.” Trump said he’s letting Attorney General William Barr handle the investigation into Bolton and he isn’t getting involved.

Of James Mattis, the president said he disagreed with him “very much,” and noted that the retired United States Marine Corps general was “fired by President Obama, he was fired…like a dog he was fired.”

Trump attacked the mainstream media, calling The New York Times “stone-cold dishonest.”

“The worst lie of all is that I’m standing over the grave of soldiers from many years ago, warriors of many years ago, who I cherish. I’m very strong on the military. I love the military and I respect the military,” Trump told host Mark Levin. “And they made up a lie that I called them suckers and losers,” Trump said of The Atlantic report that used anonymous sources. Trump said that he doesn’t read The Atlantic, adding “most other people don’t either.”

Trump stated he would like to strengthen the nation’s libel laws.

Trump said, “Every one of these cities that has problems is run by Democrats.”

He pointed out that people have gotten desensitized about the violence in Chicago. “Look at Chicago, where 58 people were shot. Now the reports are, ’58 people were shot this weekend in Chicago, ten died, okay, now let’s get on to the weather.’ They’ve gotten almost used to it.”

Trump also talked about mail-in voting and called them “unsolicited ballots.”

“They have no idea who they’re sending them to, you know they’re sending them to the wrong people,” Trump stated, adding that Democrats “want it to be a mess.”

Trump said that Democrats and the mainstream media are “denigrating” a potential COVID-19 vaccine that could save lives. Trump claimed that his political rivals and the media are creating a “terrible situation” instead of being hopeful about obtaining a coronavirus vaccine “in record time,” and not in “two or three years.”

“Instead of saying, ‘Wow, that’s great. It’s going to save a lot of lives and people are going to be protected, and this whole thing will end faster’ … They started denigrating it,” he told Levin.

Trump accused the media and Democrats of downplaying the potential coronavirus vaccine, “when actually it’s one of the greatest things that anyone’s done, and I’m not saying me – I’m saying anyone. It’s so incredible.”

“You would think they’d be happy and thrilled and jumping up and down,” Trump told Levin. “Instead … it’s just a terrible situation.”

“The reason they’re doing it is because they think I’ll get credit if we have a vaccine anywhere near the election, but certainly before the election,” Trump claimed. “But essentially we’re there now anyway, and we’re ready to distribute very rapidly.”

Earlier this month, Trump said that a COVID-19 vaccine could be ready “during the month of October,” right before the Nov. 3 presidential election.

“It’s a tremendous thing that they’ve done and we’ve all done together,” Trump continued. “Then we’re ready to distribute it very quickly, and we’ll do our senior citizens first – the most vulnerable, … especially if they have a problem with a heart or they have diabetes or something.”

“I have totally changed the FDA process,” Trump said. “Same safety, but the speed is from a different world, and we should have the vaccine approved very soon.”

The president praised the “great companies” attempting to develop a COVID-19 vaccine, including Johnson & Johnson, Pfizer, and Moderna. The pharmaceutical companies are in Phase 3 trials, “right at the end of the process.” Last week, Trump announced that the COVID-19 vaccine would be distributed within 24 hours of completion of Phase 3 trials and approval by the FDA.

Levin mentioned Democratic governors who ordered nursing homes and long-term care facilities to accept patients who were infected with COVID-19.

Share
Categories
2020 Election Coronavirus vaccine Covid vaccine Intelwars Life liberty & levin Mark Levin President Trump President trump interview

President Trump warns US could become Venezuela on steroids, tells Mark Levin: Biden ‘doesn’t know he’s alive’

With only a month and a half until the 2020 election, President Donald Trump gave an in-depth interview on Fox News’ “Life, Liberty, & Levin,” where he discussed the potential coronavirus vaccine, Joe Biden, mail-in voting, and the mainstream media.

“You know it and I know it, Joe doesn’t know he’s alive,” Trump said of the former vice president. “It’s a sad thing that’s going on. The whole thing is a sad thing.”

Trump called Biden’s running mate Kamala Harris the “most liberal person in the Senate.”

The president warned that if policies from far-left Democrats are instituted, the U.S. could become the next Venezuela.

“And I used to say we’ll be another Venezuela, but I never really…I don’t know that I believed it fully,” he revealed. “That wasn’t too long ago. But I do. If that kind of stuff gets put in, we will be another Venezuela, except on major steroids.”

Trump called former White House national security adviser John Bolton a “stupid person.” He added, “What he did, I think was highly illegal, I mean his book is loaded up with confidential and classified information.” Trump said he’s letting Attorney General William Barr handle the investigation into Bolton and he isn’t getting involved.

Of James Mattis, the president said he disagreed with him “very much,” and noted that the retired United States Marine Corps general was “fired by President Obama, he was fired…like a dog he was fired.”

Trump attacked the mainstream media, calling The New York Times “stone-cold dishonest.”

“The worst lie of all is that I’m standing over the grave of soldiers from many years ago, warriors of many years ago, who I cherish. I’m very strong on the military. I love the military and I respect the military,” Trump told host Mark Levin. “And they made up a lie that I called them suckers and losers,” Trump said of The Atlantic report that used anonymous sources. Trump said that he doesn’t read The Atlantic, adding “most other people don’t either.”

Trump stated he would like to strengthen the nation’s libel laws.

Trump said, “Every one of these cities that has problems is run by Democrats.”

He pointed out that people have gotten desensitized about the violence in Chicago. “Look at Chicago, where 58 people were shot. Now the reports are, ’58 people were shot this weekend in Chicago, ten died, okay, now let’s get on to the weather.’ They’ve gotten almost used to it.”

Trump also talked about mail-in voting and called them “unsolicited ballots.”

“They have no idea who they’re sending them to, you know they’re sending them to the wrong people,” Trump stated, adding that Democrats “want it to be a mess.”

Trump said that Democrats and the mainstream media are “denigrating” a potential COVID-19 vaccine that could save lives. Trump claimed that his political rivals and the media are creating a “terrible situation” instead of being hopeful about obtaining a coronavirus vaccine “in record time,” and not in “two or three years.”

“Instead of saying, ‘Wow, that’s great. It’s going to save a lot of lives and people are going to be protected, and this whole thing will end faster’ … They started denigrating it,” he told Levin.

Trump accused the media and Democrats of downplaying the potential coronavirus vaccine, “when actually it’s one of the greatest things that anyone’s done, and I’m not saying me – I’m saying anyone. It’s so incredible.”

“You would think they’d be happy and thrilled and jumping up and down,” Trump told Levin. “Instead … it’s just a terrible situation.”

“The reason they’re doing it is because they think I’ll get credit if we have a vaccine anywhere near the election, but certainly before the election,” Trump claimed. “But essentially we’re there now anyway, and we’re ready to distribute very rapidly.”

Earlier this month, Trump said that a COVID-19 vaccine could be ready “during the month of October,” right before the Nov. 3 presidential election.

“It’s a tremendous thing that they’ve done and we’ve all done together,” Trump continued. “Then we’re ready to distribute it very quickly, and we’ll do our senior citizens first – the most vulnerable, … especially if they have a problem with a heart or they have diabetes or something.”

“I have totally changed the FDA process,” Trump said. “Same safety, but the speed is from a different world, and we should have the vaccine approved very soon.”

The president praised the “great companies” attempting to develop a COVID-19 vaccine, including Johnson & Johnson, Pfizer, and Moderna. The pharmaceutical companies are in Phase 3 trials, “right at the end of the process.” Last week, Trump announced that the COVID-19 vaccine would be distributed within 24 hours of completion of Phase 3 trials and approval by the FDA.

Levin mentioned Democratic governors who ordered nursing homes and long-term care facilities to accept patients who were infected with COVID-19.

Share
Categories
Coronavirus Coronavirus vaccine Covid vaccine COVID-19 Covid-19 vaccine Intelwars President Trump

Trump accuses Democrats and media of ‘denigrating’ potential coronavirus vaccine: ‘It’s just a terrible situation’

President Donald Trump accused Democrats and the mainstream media of “denigrating” a potential coronavirus vaccine that could save lives. The president said his political opponents and the media are creating a “terrible situation” instead of being excited about the possibility of getting a COVID-19 vaccine “in record time.”

Earlier this month, Trump said that a coronavirus vaccine could be ready “during the month of October,” right before the Nov. 3 presidential election.

“And what’s happening is, all of a sudden, you’ll have this incredible vaccine, and because of that fake rhetoric — it’s a politic rhetoric; that’s all it is. Just for politics,” Trump said during a Sept. 7 press conference. “Because now they see we’ve done an incredible job, and in speed like nobody has ever seen before. This could’ve taken two or three years, and instead it’s going to be — it’s going to be done in a very short of period of time. Could even have it during the month of October.”

During an interview that will air Sunday on Fox News’ “Life, Liberty, & Levin,” Trump told host Mark Levin, “Instead of saying, ‘Wow, that’s great. It’s going to save a lot of lives and people are going to be protected, and this whole thing will end faster’ … They started denigrating it.”

Trump said the media and Democrats are diminishing the potential coronavirus “when actually it’s one of the greatest things that anyone’s done, and I’m not saying me – I’m saying anyone. It’s so incredible.”

“You would think they’d be happy and thrilled and jumping up and down,” Trump said. “Instead … it’s just a terrible situation.”

“The reason they’re doing it is because they think I’ll get credit if we have a vaccine anywhere near the election, but certainly before the election,” Trump told Levin. “But essentially we’re there now anyway, and we’re ready to distribute very rapidly.”

“It’s a tremendous thing that they’ve done and we’ve all done together,” Trump explained. “Then we’re ready to distribute it very quickly, and we’ll do our senior citizens first – the most vulnerable, … especially if they have a problem with a heart or they have diabetes or something.”

“I have totally changed the FDA process,” Trump added. “Same safety, but the speed is from a different world, and we should have the vaccine approved very soon.”

Joe Biden hinted that the president was politicizing the potential coronavirus vaccine.

“A vaccine would offer a way back to normalcy and a path toward better days for all of us… But it’s not going to happen overnight,” Biden said on Wednesday in Delaware. “One thing is certain, we can’t allow politics to interfere with a vaccine in any way.”

“Americans have had to endure President Trump’s incompetence and dishonesty when it comes to testing and personal protective equipment,” Biden continued. “We can’t afford to repeat those fiascos when it comes to a vaccine, when it occurs. The stakes are too high.”

“So let me be clear, I trust vaccines. I trust scientists. But I don’t trust Donald Trump. And at this moment, the American people can’t either,” the Democratic presidential nominee said.

Biden’s running mate Sen. Kamala Harris was accused of promoting a “dangerous conspiracy theory” and “anti-vaxxer” talking points for her comments about a possible COVID-19 vaccine.

When asked if she would get an approved COVID-19 vaccine, Harris said, “Well, I think that’s gonna be an issue for all of us. I will say that I would not trust Donald Trump, and it would have to be a credible source of information that talks about the efficacy and the reliability of whatever he’s talking about. I will not take his word for it.”

Harris said scientists would “be muzzled, they’ll be suppressed, they will be sidelined, because [Trump is] looking at an election coming up in less than 60 days, and he’s grasping for whatever he can get to pretend that he’s been a leader on this issue when he’s not.”

Trump praised the companies working on the coronavirus vaccine, including Johnson & Johnson, Pfizer and Moderna. The pharmaceutical companies are in Phase 3 trials. On Friday, Trump announced that the COVID-19 vaccine would be distributed within 24 hours of completion of Phase 3 trials and approval by the FDA.

On BlazeTV, Steven Crowder exposed how the mainstream media launched attacks on Trump regarding the potential of a COVID-19 vaccine this year.

Share
Categories
Coronavirus vaccine Covid-19 vaccine Donald Trump Intelwars Operation warp speed Scott atlas Vaccine

Trump admin says COVID-19 vaccine will not be mandatory, will be distributed within 24 hours of FDA approval

President Donald Trump announced Friday that a COVID-19 vaccine will be distributed within 24 hours of completion of phase 3 trials and FDA approval, with all Americans having access to the vaccine by April, according to the Daily Caller.

Speed has been the priority in the pursuit of a vaccine to provide relief to the country from the pandemic, as evidenced by the name of the initiative: Operation Warp Speed. From the Daily Caller:

“Since January, America’s brilliant doctors and scientists have been working been working around the clock, the best medical minds in the world by far and the vaccines are going through the gold standard of clinical trials, very heavy emphasis placed on safety,” Trump told reporters at the top of his Friday afternoon press conference. “Three vaccines are already in the final stage.”

The president further stated that “as part of Operation Warp Speed, my administration has manufactured one of the most promising vaccines in advance, and it will be fairly long in advance, as soon as a vaccine is approved, the administration will deliver it to the American people immediately. Distribution will begin within 24 hours.”

Trump said there should be enough doses by April for every American to have access to the vaccine.

Concerns about how safe the vaccine will be, combined with new perspective on just how heavily governments may impose requirements on citizens in an emergency, have led some to be skeptical about taking a vaccine for COVID-19.

Dr. Scott Atlas, a member of the White House coronavirus response task force, assured the public that they will have a choice in the matter.

“By April, every single American who wants to be vaccinated will have the ability to be vaccinated,” Atlas said. “It’s not a forced vaccination.”

Nearly half of surveyed Americans have said they will either definitely or probably not get a COVID-19 vaccine, according to Pew Research Center. Of that group, 76% of them cite fear of side effects as a major concern, and 72% of them say they want to know more about how well it works.

From Pew Research:

There are widespread public concerns about aspects of the vaccine development process. On the heels of a pledge from nine pharmaceutical companies to ensure that a potential vaccine would meet rigorous standards, the Center survey finds three-quarters of Americans (77%) think it’s very or somewhat likely a COVID-19 vaccine will be approved in the United States before its safety and effectiveness are fully understood. And when asked about the pace of the vaccine approval process, 78% say their greater concern is that it will move too fast, without fully establishing safety and effectiveness, compared with just 20% who are more concerned approval will move too slowly, creating unnecessary delays.

Share
Categories
Coronavirus Coronavirus vaccine COVID-19 Covid-19 vaccine Intelwars Operation warp speed pandemic Vaccine

COVID-19 vaccine to be free for all Americans, though many are skeptical about taking it

The COVID-19 vaccine will be free for all Americans who want to get it, according to a federal government plan submitted to Congress this week detailing how a vaccine will be rolled out nationwide once one is approved.

The Associated Press reported that the federal government has put together a large and complex plan for distributing a vaccine as quickly as possible, as several companies proceed with final tests on vaccines that may receive emergency use authorizations from the Food and Drug Administration due to the urgency of the pandemic.

Americans who get the vaccine won’t have to directly pay for the shots or the administration of those shots. They will be paid for using taxpayer funding allocated by the Trump administration.

Depending on the supply of the vaccine upon completion, it may initially only be accessible to members of higher-priority groups, such as health care workers, other essential workers, the elderly, and those with conditions that make them more vulnerable to serious illness or death from COVID-19. Data shows that younger, healthy people are at very low risk of serious illness from the novel coronavirus and may suffer no symptoms at all.

While there may be different vaccines from multiple drug manufacturers, the report said that most of the vaccines will require two shots to be taken between three and four weeks apart.

The rush for a vaccine under a federal initiative called Operation Warp Speed has caused concerns among the public that the resulting vaccine(s) might not be safe. There has never been a vaccine for a coronavirus, as vaccines for SARS and MERS were not developed for humans.

Some Democratic politicians have begun fueling this skepticism by suggesting that President Donald Trump will push public health agencies to cut corners in getting a vaccine approved and available before the presidential election at the beginning of November.

Democratic vice presidential nominee Sen. Kamala Harris (D-Calif.) was asked on CNN whether she would take a vaccine before the election, and she answered evasively.

“I will say that I would not trust Donald Trump and it would have to be a credible source of information that talks about the efficacy and the reliability of whatever he’s talking about,” Harris said.

President Trump said Tuesday that a vaccine could be available in three or four weeks, although Dr. Anthony Fauci has said that it is more likely to be early next year before it is widely available..

Share
Categories
Coronavirus vaccine Covid-19 vaccine Donald Trump Intelwars Ivanka Trump Joy Behar

Joy Behar says she won’t trust the COVID-19 vaccine until Ivanka Trump takes it: ‘Don’t fall for it’

“The View” co-host Joy Behar said she doesn’t trust a COVID-19 vaccine that may be released to the public by November, and she won’t take it unless President Trump’s daughter, Ivanka Trump, does, according to The Hill.

The Trump administration has been working to get a vaccine approved and distributed by the end of the year through a public-private partnership initiative called Operation Warp Speed. Behar pointed to the amount of time it took for other vaccines to be developed as reason for concern.

“[Trump] will push anything to get reelected,” Behar said. “Don’t fall for it, and by the way, I will take the vaccine after Ivanka takes it.”

“Under Operation Warp Speed, we’re producing a vaccine in record time,” the president said at a rally in North Carolina. “This is a vaccine that we’re going to have very soon, very, very soon. By the end of the year, but much sooner than that perhaps.”

From The Hill:

“As far as the vaccine is concerned, I’d like to inform America — in case we don’t know this because I looked all this up for you — the mumps vaccine took four years, the polio vaccine took 20 years, and the smallpox vaccine took a few centuries,” Behar said on ABC on Wednesday morning.

“It was developed initially in 1796, when they started to think about it, and it became useful in the 1950s. OK?” she added of the smallpox vaccine. “It is not a simple thing to do.”

“He will push anything to get reelected,” she added later, referring to President Trump. “Don’t fall for it, and by the way, I will take the vaccine after Ivanka takes it.”

The Centers for Disease Control and Prevention alerted states to be prepared for a vaccine as early as the end of October, although that doesn’t necessarily mean one will be approved by then. Several U.S. companies, and others around the world, are working on a vaccine.

An AstraZeneca vaccine trial was recently halted due to an unexplained illness in the trial that may or may not be related to the vaccine.

“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process triggered a pause to vaccination to allow review of safety data,” an AstraZeneca statement read. “This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”

Share
Categories
Coronavirus Coronavirus lockdown Coronavirus vaccine Intelwars Tedros Adhanom Ghebreyesus Vaccine Who coronavirus lockdown World Health Organization

WHO director says the world ‘cannot go back to the way things were,’ even if a vaccine is found

The director of the World Health Organization said that the world would not go back to the way it was before the coronavirus, even if a vaccine is found to combat the pandemic.

WHO Director-General Tedros Adhanom Ghebreyesus made the comments in a media briefing on Friday. He noted that several countries had seen cases fall only to see a second wave hit months later.

“Progress does not mean victory,” said Tedros.

“Even if we do have a vaccine, it wouldn’t end the pandemic on its own. We must all learn to manage and control this virus using the tools we have now, and make the adjustments to our daily lives that are needed to keep ourselves and each other safe,” he continued later in his speech.

“Lockdowns are not a long term solution”

“So-called lockdowns enabled many countries to suppress transmission and take the pressure off their health systems,” Tedros said.

“But lockdowns are not a long term solution for any country. We do not need to choose between lives and livelihoods or between health and the economy. That’s false choice. On the contrary, the pandemic is a reminder that health and the economy are inseparable,” he continued.

“WHO is committed to working with all countries to move into a new stage of opening their economies, societies, schools, and businesses safely. To do that, every single person must be involved. Every single person can make a difference. Every person, family, community and nation must make their own decisions based on the level of risk where they live,” he added.

Climate change

Tedros explained that local governments can best assess what risk they are facing and what steps to mitigate the spread of the coronavirus.

“At the same time, we will not, we cannot, go back to the way things were,” he continued.

“Throughout history, outbreaks and pandemics have changed economies and societies, this one will be no different,” Tedros added.

“In particular, the pandemic has given new impetus to the need to accelerate efforts to respond to climate change,” he said. “The pandemic has given us a glimpse of our world as it could be, cleaner skies and rivers.”

The WHO has been criticized for evidence that they were complicit in helping China hide the coronavirus during the early stages of the pandemic. Tedros himself has been accused of being too closely tied to China, with some critics noting that the country aided his ascendance to the directorship of WHO.

Here’s part of the comments from the WHO director:


WHO: The pandemic is a reminder that health and the economy are inseparable

www.youtube.com

Share
Categories
Coronavirus vaccine Covid-19 vaccine Intelwars Putin covid vaccine Russia covid vaccine

Russia claims fast-track COVID-19 vaccine victory with ‘Sputnik-V’; Putin says he gave the drug to his daughter

Russian President Vladimir Putin
says the country has approved the world’s first coronavirus vaccine.

What are the details?

Putin announced the approval for the new vaccine on Tuesday, lauding the approval as the first of its kind the world over.

On state TV, the Russian president said, “A vaccine against coronavirus has been registered for the first time in the world this morning. I know that it works quite effectively, it forms a stable immunity.”

Putin added, “I would like to repeat that it has passed all the necessary tests. We must be grateful to those who made that first step very important for our country and the entire world.”

“I hope our foreign colleagues’ work will move as well, and a lot of products will appear on an international market that could be used,” the Russian president noted.

Putin also said that one of his daughters received the vaccine and said that though it appeared to have initially elevated her temperature, “Now she feels well.”

Putin’s daughter also reportedly now “has a high number of antibodies.”

‘Sputnik-V’

CNN reports that the drug was developed by Moscow-based Gamaleya Institute and has been named “Sputnik-V.”

The outlet adds that the expeditiousness of the Russian vaccine is due in part to “political pressure from the Kremlin,” which reportedly aims to portray the country as a “global scientific force.”

“Russia has released no scientific data on its testing,” the outlet reports.

Russian officials reportedly told the network that at least 20 countries across the world — and even some U.S. companies — have expressed interest in the vaccine.

The Associated Press on Tuesday reported that many in the worldwide scientific community are concerned over the announcement and insist that fast-tracking such a drug, and skipping Phase 3 trials, could ultimately backfire.

At the time of this writing, researchers at Johns Hopkins University estimate that there have been at least 895,691 confirmed COVID-19 cases in Russia, with at least 15,103 deaths attributed to the deadly virus.

Share
Categories
Coronavirus Coronavirus vaccine covid Covid-19 vaccine Intelwars Vaccine

Only 42% of Americans say they would get a COVID-19 vaccine if it were available

From the get-go with the coronavirus, experts have told us that what will save us is a vaccine.

But a new poll published Tuesday reveals that a steadily decreasing share of Americans — significantly less than half — say they are willing to get the COVID-19 vaccine should one ever be developed, Yahoo News reported.

What did people say about getting vaccinated?

Polling by Yahoo News and YouGov have found fewer and fewer of us are planning to get a COVID vaccine once one is developed.

When the surveys first began in early May, 55% of all Americans said they would get vaccinated. That number has shrunk every time the poll has been conducted.

In late may, 50% said they would be vaccinated; by early July, that number had dropped to 46%.

Now the number is even lower. In a Yahoo News/YouGov poll conducted July 28-30, pollsters found that only 42% of all Americans said they would get vaccinated “if and when a coronavirus vaccine becomes available.”

Broken down politically — because every thing is nowadays — the poll reported that just 55% of Democrats and 37% of Republicans were planning to get vaccinated. Independents were even less likely than GOPers, coming in at 34%. Also, 62% of presumptive Democratic presidential nominee Joe Biden’s supporters would take the vaccine, compared to just 35% of supporters of President Donald Trump.

The number is interesting considering the share of people who say they are worried about COVID-19. According to the survey, 73% of Americans are worried about the virus, while 27% are not. However, only 42% of people think it’s it is likely they’ll get the virus, and 58% said it’s unlikely.

Perhaps the biggest reason for not wanting to get vaccinated is concern over the safety of a fast-tracked vaccine. According to the poll, 69% of Americans are concerned about the safety factor, and 24% are not.

Only 44% of people trust the CDC and public health authorities to judge the risk of a COVID vaccine.

So, what do people support more than vaccines?

For starters, 73% of us want wearing face masks in public to be mandatory — 27% disagree.

And 60% of our fellow citizens think another stay-at-home order would be a good idea. Only 28% disagree. Which fits with the finding that only 29% of those polled said they were worried about reopening the economy too slowly.

Share
Categories
AstraZeneca Coronavirus Coronavirus vaccine COVID-19 Covid-19 vaccine Intelwars Moderna Pfizer

Vaccine developer says people must wear masks and socially distance even after vaccine is available

A vaccine developer at the Baylor College of Medicine told Business Insider that people should not expect an immediate return to normal life once a vaccine is available.

Several companies are working as quickly as possible to develop a safe and effective vaccine, which has been viewed by some as necessary for lockdowns to end and schools to reopen. While a vaccine may significantly reduce the risk of serious disease from the novel coronavirus, social distancing and face masks may still be a part of life, said vaccine developer Maria Elena Bottazzi.

“They automatically are going to say, ‘oh great, I’m just going to get my little vaccine, and I can go back and do exactly the things I was doing last year,'” Bottazzi told Business Insider. “That is absolutely not true.”

Ideally, Bottazzi said, a vaccine would give sterilizing immunity, meaning it would totally prevent people from becoming infected. Many vaccines don’t reach that level of effectiveness, however, and only reduce the chance of developing severe symptoms of a particular disease.

Vaccines improve over time, which means the first version of the COVID-19 vaccine that is made available to the public might not be 100% effective. In fact, Moderna’s vaccine, which is entering phase 3 of trials, is aiming to demonstrate 60% effectiveness.

Moderna CEO Stephanie Bancel said that if the vaccine reaches 90% effectiveness, then people can safely stop wearing masks — unless they have high-risk health conditions, in which case they may need to continue wearing them. Bancel said the company hopes to know more about their vaccine’s efficacy as early as October or as late as December.

For comparison, the 2019-2020 flu vaccine is only about 45% effective against the seasonal flu and typically ranges between 40% and 60% effectiveness every year. A vaccine was never successfully developed for the SARS coronavirus in 2002, and eventually demand for such a vaccine went away, as the virus ran its course and mostly disappeared without spreading nearly as widely as COVID-19 has.

In summary, the masks could be here to stay through the end of 2020, and potentially even longer depending on how successful the COVID-19 vaccines are.

“The moment you get a vaccine doesn’t mean you’re going to put your mask in the trash,” Bottazzi told Business Insider. “That is not going to happen. I hope people don’t think that is going to be the magic solution for all.”

Share
Categories
Coronavirus vaccine Covid-19 vaccine Espionage FSB GRU Hackers Intelwars Russia

US, UK, and Canada accuse Russia of trying to steal coronavirus vaccine research

Hackers linked to Russian intelligence services are attempting to steal coronavirus vaccine research from pharmaceutical companies and other organizations, according to security officials from the U.S., the U.K., and Canada.

The three nations alleged on Thursday that hacking group APT29, also known as “Cozy Bear” and “the Dukes,” is trying to steal COVID-19 vaccine research. The U.S. National Security Agency, U.K.’s National Cyber Security Centre, and Canada’s Communications Security Establishment all agree that the hacker group is “almost certainly part of the Russian intelligence services.”

“Throughout 2020, APT29 has targeted various organizations involved in COVID-19 vaccine development in Canada, the United States and the United Kingdom, highly likely with the intention of stealing information and intellectual property relating to the development and testing of COVID-19 vaccines,” according to the U.K.’s National Cyber Security Centre. “The group uses a variety of tools and techniques to predominantly target governmental, diplomatic, think-tank, healthcare and energy targets for intelligence gain.”

APT29, which is associated with the Russian military spy agency GRU, is reportedly using custom malicious software to target organizations around the world. The malware being used is called “WellMess” and “WellMail,” according to the 16-page advisory.

Targets include health care agencies, pharmaceutical companies, academia, medical research organizations, and local governments, security officials warned.

“In recent attacks targeting COVID-19 vaccine research and development, the group conducted basic vulnerability scanning against specific external IP addresses owned by the organizations,” the joint advisory stated. “The group then deployed public exploits against the vulnerable services identified.”

“It is completely unacceptable that the Russian Intelligence Services are targeting those working to combat the coronavirus pandemic,? said Dominic Raab, Britain’s foreign secretary. “While others pursue their selfish interests with reckless behavior, the U.K. and its allies are getting on with the hard work of finding a vaccine and protecting global health.”

“APT29 is likely to continue to target organizations involved in COVID-19 vaccine research and development, as they seek to answer additional intelligence questions relating to the pandemic,” the advisory concludes.

Russia has denied the allegations.

“We do not have information on who might have hacked into pharmaceutical companies and research centers,” Russian spokesman Dmitry Peskov told the TASS news agency. “We can only say one thing: Russia has nothing to do with these attempts. We do not accept these accusations, as well as the usual accusations of interference in the 2019 (sic) election.”

U.S. officials have made similar accusations about theft of COVID-19 research against China.

“At this very moment, China is working to compromise American health care organizations, pharmaceutical companies, and academic institutions conducting essential COVID-19 research,” FBI Director Chris Wray said last week.

Cozy Bear was identified as one of the Russian-linked groups that hacked into the Democratic National Committee computer network and stole emails and phone calls before the 2016 presidential election.

In early April, the U.S. Department of Homeland Security issued a warning that cyber espionage groups were attempting to exploit the coronavirus pandemic.

“Both [Cybersecurity and Infrastructure and Security Agency] and [National Cyber Security Centre] are seeing a growing use of COVID-19-related themes by malicious cyber actors,” the alert stated. “At the same time, the surge in teleworking has increased the use of potentially vulnerable services, such as virtual private networks, amplifying the threat to individuals and organizations.”

Share
Categories
Coronavirus lockdown Coronavirus vaccine Governor phil murphy Intelwars New Jersey

RIP ‘flattening the curve’: Gov. Murphy says New Jersey won’t return to normal until ‘a proven vaccine is widely available’

You may have thought that the social distancing measures forced upon us by our governments were designed to help “flatten the curve,” ensuring that there weren’t excess deaths caused by COVID-19 due to hospitals being overwhelmed. You may have thought that because government officials repeatedly stated that this was the justification for keeping us all locked in our houses.

You may have also noticed that the goalposts seemed to move an awful lot during the last few weeks, when it became obvious that hospitals were not going to be overwhelmed in the vast majority of the country, and yet many states remained closed down. Many governors and media figures started acting like the goal all along had been to completely eradicate the disease via vaccine before Americans were allowed to return to normal.

Even President Trump faced hostile questioning from the media last week for insisting that the country had to get back to work whether or not a vaccine was developed.

Of course, if leaders had told us from the beginning that we would be going into lockdown until a vaccine was developed, Americans would have likely balked at the idea since the most reasonable estimates for widespread development and dissemination of a vaccine involved a timeframe of at least a year and more likely 18 months.

However, now that we’ve all been locked down for two months, some politicians feel more secure saying that the lockdowns will not fully end until there is a vaccine, no matter how long that takes. New Jersey Gov. Phil Murphy (D) made that clear in a series of tweets Monday afternoon.

Murphy’s tweet thread makes it clear that New Jersey will not fully reopen until “widespread vaccination or lifesaving treatment” has been achieved, a goal that most medical researchers say is likely more than a year away.

Gov. Murphy was clear, “Until a proven vaccine is widely available, we cannot firmly enter the ‘new normal.'”

Murphy’s bait and switch comes as cracks are already beginning to show in the state’s willingness to enforce Murphy’s orders forever. Earlier Monday, a police officer made news by refusing to enforce the governor’s order against a gym owner who publicly declared that he would reopen in defiance of that order.

Share
Categories
Coronavirus vaccine Covid-19 vaccine Intelwars Moncef slaoui Operation warp speed Vaccine czar

President Trump to tap former pharma exec for ‘Operation Warp Speed,’ wants military to distribute coronavirus vaccine by end of the year

President Donald Trump is set to tap a former pharmaceutical executive to lead “Operation Warp Speed,” his administration’s full-scale effort to produce a coronavirus vaccine by the end of the year, which will then be distributed by the U.S. military.

“You know it’s a massive job to give this vaccine,” Trump said in an interview with Fox Business’ Maria Bartiromo that aired Thursday morning. “Our military is now being mobilized so at the end of the year, we’re going to be able to give it to a lot of people very, very rapidly.”

“We will have a tremendous force because assuming we get it, then you have to distribute it,” Trump added. “And unless you’re mobilized and ready, you’re not going to be able to do it for a long time. So we’re starting now.”

The first COVID-19 vaccine doses would be made available to the elderly and most vulnerable.

Operation Warp Speed is a “Manhattan Project-style effort” that involves officials from the Defense Department and the Department of Health and Human Services to produce 300 million vaccine doses by the end of 2020.

Leading health officials, including Dr. Anthony Fauci from the White House coronavirus task force, have said that developing a coronavirus vaccine would take between 12 and 18 months.

Fauci told a Senate committee that the prospects of developing a coronavirus vaccine by the fall are unlikely.

“The idea of having treatments available or a vaccine to facilitate reentry of students into the fall term would be something that would be a bit of a bridge too far, even at the top speed we’re going,” Fauci said.

Vaccines typically take years to develop, sometimes even decades.

There are currently more than 100 coronavirus vaccines under development. Scientists at Oxford University say they are confident that a COVID-19 vaccine will be widely available by September. Researchers are testing the vaccine on humans and expect to conduct over 6,000 tests by the end of May.

Trump is expected to tap Moncef Slaoui, a former executive at GlaxoSmithKline, to lead Operation Warp Speed, according to Politico. Slaoui, who was previously the head of GlaxoSmithKline’s vaccine division, will serve in a volunteer role as Trump administration’s “therapeutics czar” or “vaccine czar” in the fight against the novel coronavirus.

Slaoui will be assisted by Army Gen. Gustave Perna, a logistics expert and commander of United States Army Materiel Command. Slaoui sits on the board of Moderna, which is a biotech company based in Massachusetts that is working on a coronavirus vaccine.

Last month, GlaxoSmithKline teamed up with French drug giant Sanofi to develop a coronavirus vaccine. Trials have not started yet, and they expect a possible vaccine by the second half of 2021.

Share
Categories
CNN Coronavirus Coronavirus vaccine Gallup Intelwars Mainstream media Media Bias

Viral CNN claim about COVID-19 vaccine, returning to ‘normal life’ completely misrepresented poll results

CNN claimed in a viral tweet this week that a recent Gallup survey showed the vast majority of Americans said they “need” a coronavirus vaccine before returning to normal life.

“68% of Americans say a coronavirus vaccine is needed before returning to normal life, a new survey finds,” CNN blasted on Twitter.

Image source: Twitter screenshot

As presented, the poll seemingly indicated support for extended lockdown orders because Americans remain too fearful to return to normal life.

Except that’s not what the Gallup survey indicated. In fact, CNN completely misrepresented what the poll found.

What did Gallup find?

Gallup asked: “How important are each of the following factors to you when thinking about your willingness to return to your normal activities?”

When specifically asked about a COVID-19 vaccine, 68% of respondents answered “very important.”

The respondents, however, did not say they “needed” a vaccine to return to normal life. Instead, they merely indicated that a vaccine is important when considering their willingness to return to normal life, which does not actually suggest they would not return to normal life without a vaccine.

Nicholas Grossman of ArcDigital wrote:

The article doesn’t link to any polls— never a good sign — but mentions “two Gallup surveys.” I searched Gallup’s polling on coronavirus, and the survey questions are less ambiguous regarding “normal life,” with results that differ substantially from CNN’s claim.

One question asks “how soon would you return to your normal day-to-day activities” if “there were no government restrictions,” giving four options. The most popular answer is “after the number of new cases declines significantly,” getting 40 percent in the most recent survey. The least popular answer is “after a coronavirus vaccine is developed.” Only 9 percent went with that.

Nine percent, you may have noticed, is less than 68 percent.

How did CNN respond?

The news outlet deleted its tweet with the false claim, and added a clarification to its story.

“CLARIFICATION: The headline on this post was updated to clarify that the survey found 68% of Americans say an available vaccine is very important before returning to normal life. The post was also clarified to emphasize that respondents were rating the importance of each benchmark to their willingness to return to regular activities,” the clarification says.

Grossman responded by saying that CNN’s clarified headline is not the “best framing” because the story still cherry-picks the Gallup survey to project its vaccines-are-necessary-to-end-lockdowns narrative.

But, Grossman wrote, “Unlike the original headline, the new one accurately conveys something in the Gallup survey.”

(H/T: Mediaite)

Share
Categories
Coronavirus antibody Coronavirus response Coronavirus vaccine Intelwars ISRAEL pandemic Vaccine

Israeli lab says they have reached a coronavirus antibody breakthrough, will begin mass production

The Israel Institute for Biological Research announced on Monday that they had completed the development phase of an antibody to battle the coronavirus, and it will head to mass production.

Israeli Defense Minister Naftali Bennett visited the lab on Monday and made a joint announcement about the advancement.

“A significant breakthrough has been achieved in finding an antidote to the Corona virus that attacks the virus and can neutralize it in the sick body,” read the statement from the IIBR and Bennett.

The IIBR is seeking to patent the antibody and to produce it commercially in partnership with the Israeli Defense Ministry.

“I am proud of the Biological Institute staff, who have made a major breakthrough,” said Bennett according to the Jerusalem Post.

“The Jewish creativity and ingenuity brought about this amazing achievement,” he added.

Israel has more than 16,000 confirmed coronavirus cases, with only 234 deaths from the virus. The country is on track to begin reopening after seeing a decline in cases and deaths in recent days.

There have been protests from desperate business owners demanding that Prime Minister Benjamin Netanyahu allow the open-air markets to operate once again.

Here’s more about coronavirus is Israel:


Covid-19 infections in Israel still down

www.youtube.com

Share
Categories
70 vaccines Coronavirus america Coronavirus outbreak Coronavirus Pandemic Coronavirus response Coronavirus us Coronavirus vaccine Covid-19 vaccine Intelwars Oxford University UK Vaccine WHO World Health Organization

70 coronavirus vaccines are in development around the world — an Oxford scientist says one could be ready by September

One of Britain’s top scientists leading the effort to produce a COVID-19 vaccine recently said she is “80%” confident that a vaccine could be ready by September.

Sarah Gilbert, a professor of vaccinology at Oxford University, told the Times of London over the weekend that her team is set to begin human trials on its potential vaccine by the end of April. By September, the product could be ready for distribution — but only “if everything goes perfectly,” she acknowledged.

“I think there’s a high chance that it will work based on other things that we have done with this type of vaccine,” Gilbert said. “It’s not just a hunch and as every week goes by we have more data to look at. I would go for 80%, that’s my personal view.”

Gilbert’s team is one of numerous teams around the world working diligently — and at unprecedented speed — to come up with a working vaccine to fight the global coronavirus pandemic that has infected at least 1.8 million and killed over 115,000 people worldwide.

The World Health Organization announced Saturday that there are 70 vaccines currently in development around the world, with three of them already being tested in human trials.

According to Time magazine, the vaccine that is furthest along in the clinical process is being developed by Hong Kong-listed CanSino Biologics and the Beijing Institute of Biotechnology That vaccine is in phase 2 of human testing. Two others being developed in the United States by Inovio Pharmaceuticals and Moderna, along with the National Institute of Allergies and Infectious Diseases, are currently in phase 1 of human testing.

The University of Oxford vaccine candidate could be the fourth product to begin human trials in the coming weeks.

Another vaccine being developed in the U.S. by a team of researchers at the University of Pittsburgh are in the pre-clinical stage and are currently seeking fast-tracked approval for testing from the Food and Drug Administration.

Dr. Anthony Fauci, a leading health official on the White House coronavirus task force, previously cautioned Americans that it would likely be 12-18 months before a vaccine could be developed. Until further notice that conventional wisdom still stands.

But the hope is that scientific innovation and ingenuity will speed the process and shorten the time period.

Gilbert is certainly hopeful about her team’s vaccine, but was careful to add that “nobody can promise it’s going to work.”

Share
Categories
Coronavirus Coronavirus america Coronavirus outbreak Coronavirus us Coronavirus vaccine COVID-19 Covid-19 vaccine Intelwars patch Pittsburgh Pittsburgh vaccine Researchers Spike protein University of Pittsburgh Vaccine

University of Pittsburgh researchers say they have developed a potential COVID-19 vaccine

Researchers at the University of Pittsburgh School of Medicine believe they have developed a potential vaccine for COVID-19.

The researchers announced the news in a study published in EBioMedicine Thursday, calling the potential vaccine a “promising immunization strategy” and noting that it could be introduced and distributed quickly enough to “significantly impact the spread of disease.”

The vaccine, called PittCoVacc, is made of dissolvable sugar and bits of a particular protein known as the spike protein, which the virus uses to attach to cells and infect its host. When tested in mice, it was found to produce what is thought to be the sufficient number of antibodies needed to counteract the virus.

The researchers said they were able to move so quickly because of their past work developing potential vaccines for similar coronaviruses such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).

“We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014. These two viruses, which are closely related to SARS-CoV-2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,” said co-senior author Andrea Gambotto, M.D., associate professor of surgery at the Pitt School of Medicine.

“We knew exactly where to fight this new virus,” he added.

The possible vaccine was developed the old-fashioned way “using lab-made pieces of viral protein to build immunity,” according to a news release from the school — the same way current flu shots work. But it is delivered in a novel way, using a small fingertip-sized patch, similar to a BandAid. The patch goes on and then 400 tiny needles deliver the vaccine into the skin, where the immune reaction is the strongest.

“It’s actually pretty painless — it feels kind of like Velcro,” co-senior author Louis Falo, M.D., Ph.D., professor and chair of dermatology at Pitt’s School of Medicine and UPMC, said.

The researchers are now seeking approval from the U.S. Food and Drug Administration in order to advance to testing in humans, and they hope that the FDA will fast-track the normally lengthy process.

“Testing in patients would typically require at least a year and probably longer,” Falo said. “This particular situation is different from anything we’ve ever seen, so we don’t know how long the clinical development process will take. Recently announced revisions to the normal processes suggest we may be able to advance this faster.”


Pitt Unveils Possible Coronavirus Vaccine

youtu.be

Share
Categories
anthony fauci Coronavirus Coronavirus america Coronavirus outbreak Coronavirus us Coronavirus vaccine COVID-19 Intelwars

READY: U.S. researchers have begun the first set of coronavirus vaccine clinical tests

U.S. researchers have started the the initial phases of clinical safety testing for a potential coronavirus vaccine on Monday, marking the beginning of a long, multi-step process.

According to the Associated Press, which first reported the story, the clinical trial of healthy adults began Monday in hard-hit Washington state:

With a careful jab in a healthy volunteer’s arm, scientists at the Kaiser Permanente Washington Research Institute in Seattle begin an anxiously awaited first-stage study of a potential COVID-19 vaccine developed in record time after the new virus exploded from China and fanned across the globe.

“We’re team coronavirus now,” Kaiser Permanente study leader Dr. Lisa Jackson said on the eve of the experiment. “Everyone wants to do what they can in this emergency.”

The Associated Press observed as the study’s first participant, an operations manager at a small tech company, received the injection inside an exam room. Three others were next in line for a test that will ultimately give 45 volunteers two doses, a month apart.

One of the study participants, a 43-year-old woman from Seattle, told the outlet that taking part in the trial was “an amazing opportunity for me to do something,” in response to the global outbreak.

A Monday statement from the National Institutes for Health explained that the vaccine being tested is called is called mRNA-1273 and that it was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) “and their collaborators at the biotechnology company Moderna, Inc.,” which is based in Massachusetts.

“The investigational vaccine was developed using a genetic platform called mRNA (messenger RNA),” NIH says. “The investigational vaccine directs the body’s cells to express a virus protein that it is hoped will elicit a robust immune response. The mRNA-1273 vaccine has shown promise in animal models, and this is the first trial to examine it in humans.”

While NIAID Director Anthony S. Fauci, M.D. has previously said that the whole process of getting a vaccine out for public consumption “is going to take a year, a year and a half, at least,” according to Business Insider, he praised Monday’s development as a key step in the right direction.

“Finding a safe and effective vaccine to prevent infection with [coronavirus] is an urgent public health priority,” Fauci said in a written statement on Tuesday. “This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”

The Associated Press also points out that “dozens” of other research groups are around the world are also working to develop a vaccine and that trials for another candidate developed by Inovio Pharmaceuticals, is expected to begin a separate safety study in multiple countries next month.

In its own statement about Monday’s news, Moderna said that it’s already looking ahead and preparing for the next steps of the clinical trial process.

“In order to continue to progress this potential vaccine during the the ongoing global public health emergency, Moderna intends to work with the FDA and other government and non-government organizations to be ready for a Phase 2 and any subsequent trials, which are anticipated to include a larger number of subjects and which will seek to generate additional safety and immunogenicity data,” the company said in a news release about the trials. “Manufacture of the mRNA-1273 material for the potential Phase 2 trial, which could begin in a few months, is underway.”

Share
Categories
anthony fauci Coronavirus Coronavirus america Coronavirus outbreak Coronavirus us Coronavirus vaccine COVID-19 Intelwars

US researchers have begun the first set of coronavirus vaccine clinical tests

U.S. researchers have started the initial phases of clinical safety testing for a potential coronavirus vaccine, marking the beginning of a long, multistep process.

According to the Associated Press, which first reported the story, the clinical trial of healthy adults began Monday in hard-hit Washington state:

With a careful jab in a healthy volunteer’s arm, scientists at the Kaiser Permanente Washington Research Institute in Seattle begin an anxiously awaited first-stage study of a potential COVID-19 vaccine developed in record time after the new virus exploded from China and fanned across the globe.

“We’re team coronavirus now,” Kaiser Permanente study leader Dr. Lisa Jackson said on the eve of the experiment. “Everyone wants to do what they can in this emergency.”

The Associated Press observed as the study’s first participant, an operations manager at a small tech company, received the injection inside an exam room. Three others were next in line for a test that will ultimately give 45 volunteers two doses, a month apart.

One of the study participants, a 43-year-old woman from Seattle, told the outlet that taking part in the trial was “an amazing opportunity for me to do something,” in response to the global outbreak.

A Monday statement from the National Institutes for Health explained that the vaccine being tested is called mRNA-1273 and that it was developed by scientists at the National Institute of Allergy and Infectious Diseases “and their collaborators at the biotechnology company Moderna, Inc.,” which is based in Massachusetts.

“The investigational vaccine was developed using a genetic platform called mRNA (messenger RNA),” NIH says. “The investigational vaccine directs the body’s cells to express a virus protein that it is hoped will elicit a robust immune response. The mRNA-1273 vaccine has shown promise in animal models, and this is the first trial to examine it in humans.”

While Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, has previously said that the whole process of getting a vaccine out for public consumption “is going to take a year, a year and a half, at least,” according to Business Insider, he praised Monday’s development as a key step in the right direction.

“Finding a safe and effective vaccine to prevent infection with [coronavirus] is an urgent public health priority,” Fauci said in a written statement Monday. “This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”

The Associated Press also pointed out that “dozens” of other research groups around the world are also working to develop a vaccine and that trials for another candidate developed by Inovio Pharmaceuticals, is expected to begin a separate safety study in multiple countries next month.

In its own statement about Monday’s news, Moderna said that it’s already looking ahead and preparing for the next steps of the clinical trial process.

“In order to continue to progress this potential vaccine during the the ongoing global public health emergency, Moderna intends to work with the FDA and other government and non-government organizations to be ready for a Phase 2 and any subsequent trials, which are anticipated to include a larger number of subjects and which will seek to generate additional safety and immunogenicity data,” the company said in a news release about the trials. “Manufacture of the mRNA-1273 material for the potential Phase 2 trial, which could begin in a few months, is underway.”

Share